These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 14645698

  • 21. Laminin 5 gamma 2 chain expression: a marker of early invasiveness in colorectal adenomas.
    Lenander C, Roblick UJ, Habermann JK, Ost A, Tryggvason K, Auer G.
    Mol Pathol; 2003 Dec; 56(6):342-6. PubMed ID: 14645697
    [Abstract] [Full Text] [Related]

  • 22. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis.
    Baldus SE, Mönig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Hölscher AH, Dienes HP.
    Clin Cancer Res; 2004 Apr 15; 10(8):2790-6. PubMed ID: 15102686
    [Abstract] [Full Text] [Related]

  • 23. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
    Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL.
    Clin Cancer Res; 2001 Dec 15; 7(12):4013-20. PubMed ID: 11751495
    [Abstract] [Full Text] [Related]

  • 24. 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential.
    Yao T, Kouzuki T, Kajiwara M, Matsui N, Oya M, Tsuneyoshi M.
    J Pathol; 1999 Apr 15; 187(5):511-7. PubMed ID: 10398114
    [Abstract] [Full Text] [Related]

  • 25. Dysregulation of beta-catenin is common in canine sporadic colorectal tumors.
    McEntee MF, Brenneman KA.
    Vet Pathol; 1999 May 15; 36(3):228-36. PubMed ID: 10332831
    [Abstract] [Full Text] [Related]

  • 26. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
    Saldanha G, Ghura V, Potter L, Fletcher A.
    Br J Dermatol; 2004 Jul 15; 151(1):157-64. PubMed ID: 15270885
    [Abstract] [Full Text] [Related]

  • 27. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
    Kermanshahi TR, Jayachandran P, Chang DT, Pai R.
    Appl Immunohistochem Mol Morphol; 2014 Jul 15; 22(10):728-34. PubMed ID: 25394300
    [Abstract] [Full Text] [Related]

  • 28. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
    Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM.
    World J Gastroenterol; 2002 Dec 15; 8(6):987-93. PubMed ID: 12439911
    [Abstract] [Full Text] [Related]

  • 29. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.
    Hao X, Palazzo JP, Ilyas M, Tomlinson I, Talbot IC.
    Anticancer Res; 1997 Dec 15; 17(3C):2241-7. PubMed ID: 9216695
    [Abstract] [Full Text] [Related]

  • 30. Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases.
    Tatsumi N, Mukaisho K, Mitsufuji S, Tatsumi Y, Sugihara H, Okanoue T, Hattori T.
    Dig Dis Sci; 2005 Sep 15; 50(9):1741-6. PubMed ID: 16133982
    [Abstract] [Full Text] [Related]

  • 31. Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours.
    Hao X, Tomlinson I, Ilyas M, Palazzo JP, Talbot IC.
    Virchows Arch; 1997 Sep 15; 431(3):167-72. PubMed ID: 9334837
    [Abstract] [Full Text] [Related]

  • 32. Expression of beta-catenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas.
    Bismar TA, Humphrey PA, Grignon DJ, Wang HL.
    Am J Clin Pathol; 2004 Apr 15; 121(4):557-63. PubMed ID: 15080308
    [Abstract] [Full Text] [Related]

  • 33. P53 and beta-catenin in colorectal cancer progression.
    Valentini AM, Pirrelli M, Renna L, Armentano R, Caruso ML.
    Curr Pharm Des; 2003 Apr 15; 9(24):1932-6. PubMed ID: 12871177
    [Abstract] [Full Text] [Related]

  • 34. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
    Miyamoto S, Endoh Y, Hasebe T, Ishii G, Kodama K, Goya M, Ono M, Saitoh N, Chiba T, Ochiai A.
    Oncol Rep; 2004 Aug 15; 12(2):245-51. PubMed ID: 15254684
    [Abstract] [Full Text] [Related]

  • 35. Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis.
    Hao X, Frayling IM, Willcocks TC, Han W, Tomlinson IP, Pignatelli MN, Pretlow TP, Talbot IC.
    Virchows Arch; 2002 Apr 15; 440(4):362-6. PubMed ID: 11956815
    [Abstract] [Full Text] [Related]

  • 36. [Expressions of beta-catenin, p53 and proliferating cell nuclear antigen in the carcinogenesis of colorectal adenoma].
    Wu W, Zhang X, Yan X, Wang J, Zhang J, Li Y.
    Zhonghua Zhong Liu Za Zhi; 2002 May 15; 24(3):264-7. PubMed ID: 12515622
    [Abstract] [Full Text] [Related]

  • 37. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K, Kinoshita I, Shimizu Y, Ohba Y, Itoh T, Matsuno Y, Shichinohe T, Dosaka-Akita H.
    BMC Cancer; 2008 Nov 08; 8():328. PubMed ID: 18992165
    [Abstract] [Full Text] [Related]

  • 38. Molecular characteristics of serrated adenomas of the colorectum.
    Sawyer EJ, Cerar A, Hanby AM, Gorman P, Arends M, Talbot IC, Tomlinson IP.
    Gut; 2002 Aug 08; 51(2):200-6. PubMed ID: 12117880
    [Abstract] [Full Text] [Related]

  • 39. P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study.
    Walsh SV, Loda M, Torres CM, Antonioli D, Odze RD.
    Am J Surg Pathol; 1999 Aug 08; 23(8):963-9. PubMed ID: 10435567
    [Abstract] [Full Text] [Related]

  • 40. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma.
    Logani S, Oliva E, Arnell PM, Amin MB, Young RH.
    Mod Pathol; 2005 Jan 08; 18(1):19-25. PubMed ID: 15389251
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.